Meet Cromos Pharma at SCOPE 2022

Cromos Pharma is delighted to be taking part in SCOPE Summit 2022  which will take place February 7-10, 2022 in Orlando, FL. We look forward to meeting partners and potential clients to hear about your clinical program plans.

We look forward to sharing with you the advantages of partnering with Cromos Pharma including:

  • International expertise combined with in-depth regional knowledge in Central and Eastern Europe (300+ clinical trials conducted in 70+ indications). 
  • Extensive PI/site and patient network (40,000+ patients enrolled from nearly 2,500 trial sites).
  • Unparalleled patient recruitment – our team met or shortened project timelines in 95% of conducted trials.
  • Extremely short startup timelines (e.g. Georgia where we assure a study launch in less than 2 months).
  • Expertise in innovative, generics and biosimilar global studies (NDAs, ANDAs, BLAs, 505b2).
  • Regulatory inspections and audits that attest to the highest quality of data: EMA in 2019 (1-week oncology site inspection); FDA in 2017 (2-week oncology site inspection).
  • Clinical Development Strategy – we provide expert guidance on study design, favorable venues, local and global landscape to improve study outcomes.

You can also find out more about availing of Cromos Pharma’s special programs including:


Free Feasibility Reports for Sponsors considering expanding their clinical trials into Central and Eastern Europe. You confidentially provide us with your protocol, synopsis, or trial outline and in just two weeks our expert team will deliver a detailed feasibility report including: 

  • Competitive landscape 
  • Review of local standards of care 
  • Historical recruitment statistics 
  • Regulatory requirements and timelines 
  • Realistic recruitment projections


“No Patients – No Payment” is Cromos Pharma’s proprietary risk sharing program through which we give our assurance that your enrollment goals, budgets, and timelines will be met.  Simply put, if we don’t recruit – you don’t pay. 


About us

Cromos Pharma is a US-based, international contract research organization delivering fully integrated clinical research solutions, in all trial phases, across a wide range  of therapeutic areas. Our expert team, comprising 95% MDs, has expansive expertise in study design, medical writing, regulatory affairs, site management, patient recruitment and data management.

Cromos Pharma has experience in delivering success in studies from biosimilars and generics to successfully managing oncology, neurology, and dermatology clinical trials. Our team provides full-service solutions to international pharma and biotech in high-recruiting regions, assuring exceptional quality data. Cromos Pharma combines global expertise, with in-depth experience and knowledge, in Central and Eastern Europe to offer exceptional patient recruitment. Our team has met or reduced enrollment timelines in 95% of trials conducted. 

We provide accelerated study  start-up timelines in our regions of operation. We regularly achieve regulatory approvals in Georgia within two months of project signing. Regulatory inspections and site audits also attest to the highest quality of our clinical data: EMA in 2019 (1-week oncology site inspection); FDA in 2017 (2-week oncology site inspection). 

Established in 2004, Cromos Pharma has strong regional experience that is supported by a global network of offices. Its international HQ is located in Portland, Oregon, USA and European HQ in Dublin, Ireland.

Arrange a meeting with Cromos Pharma’s US Business Development Director, Nicole Brenna by emailing




To arrange an introductory meeting and find out how our experience can benefit your next clinical project.